Search Results
Session 9: Adjuvant endocrine therapy for premenopausal women: Risk stratification, type & duration
Adjuvant endocrine therapy in postmenopausal women: Risk stratification, type & duration
Endocrine therapy in premenopausal women with HR+ breast cancer
Education Session: Trends in Adjuvant Endocrine Therapy
Session 9: Adjuvant & neoadjuvant chemotherapy in patients with ER positive & HER2 negative brea...
EXTENDED ADJUVANT HORMONAL THERAPY IN EARLY BREAST CANCER
How Does Breast Cancer Index Help with Patient Selection for Extended Endocrine Therapy?
Ovarian suppression with tamoxifen reduced recurrence in some premenopausal breast cancer cases
Comment: Combining tamoxifen with ovarian suppression reduced recurrence of some breast cancers
NEJM Trial Summary: Duration of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer
Dr. Matteo Lambertini answers questions on temporary ovarian suppression
Obesity and endocrine therapy in breast cancer: Pamela Goodwin, Canada)
